Document Classification

Section Type: RESULTS

Text: Compared with the baseline, both the NGN and control groups showed a significant reduction after 12 weeks of medication in the LH level ([5. 32 + / - 2. 08] vs [4. 89 + / - 1. 46] IU/L and [5. 36 + / - 2. 07] vs [4. 81 + / - 1. 75] IU/L, P < 0. 05), psychological status score (5. 2 + / - 1. 3 vs 2. 7 + / - 1. 4 and 4. 8 + / - 2. 2 vs 2. 9 + / - 1. 2, P < 0. 05), physical status score (6. 9 + / - 2. 5 vs 2. 9 + / - 1. 6 and 7. 1 + / - 2. 7 vs 3. 1 + / - 1. 5, P < 0. 05) and sexual function score (10. 2 + / - 3. 3 vs 4. 5 + / - 2. 9 and 9. 8 + / - 3. 1 vs 4. 8 + / - 3. 0, P < 0. 05), but a remarkable increase in the TT level ([11. 13 + / - 0. 69] vs [14. 55 + / - 0. 75] nmol/L and [10. 99 + / - 0. 74] vs [14. 74 + / - 0. 83] nmol/L, P < 0. 05) and TSI ([2. 14 + / - 0. 65] vs [2. 99 + / - 0. 72] nmol/IU and ([2. 05 + / - 0. 73] vs [3. 11 + / - 0. 65] nmol/IU, P < 0. 05).